Yufei Liu
ORCID: 0000-0003-2988-8843Also affiliated with Chongqing University, Beijing University of Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Dalian University of Technology, Harvard University Press, Swansea University, China Academy of Chinese Medical Sciences, Shanghai Ocean University, Tsinghua University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial”.
Luyang Yao, Neda Kalhor, Brett W. Carter, Mehmet Altan, George Blumenschein +14 more
Yuzhuo Ma, Yufei Liu, Yin Li, Lin Wan, Ji-Feng Zhang +5 more
Haichao Li, Xiao Cui, Ruobing Feng, Weizhe Chen, Yuchen Jiang +8 more